Min Wang1,2, Zhi-Kuan Yang3,4, Hong Liu1, Rui-Qin Li1, Yu Liu2, Wen-Jun Zhong2. 1. Aier School of Ophthalmology, Central South University, Changsha, 410015, China. 2. Shanghai Aier Eye Hospital, Shanghai, 200336, China. 3. Aier School of Ophthalmology, Central South University, Changsha, 410015, China. 13380071988@189.cn. 4. Aier Institute of Optometry & Vision Science, Changsha, 410015, China. 13380071988@189.cn.
Abstract
PURPOSE: High myopia can lead to blindness. Genipin is a collagen cross-linking agent that may be used to treat myopia. However, the mechanism of action of genipin for the treatment of myopia is unclear. This study investigated the effect of genipin on the scleral expression of the miR-29 cluster, matrix metalloproteinase 2 (MMP2), and collagen alpha1 chain of type I (COL1A1) in a guinea pig model of myopia. METHODS: The model of myopia was established by treating guinea pigs with a - 8D lens on both eyes for 21 days, and eyes with a refractive error of - 6D or greater were included. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) and western blot were used to examine the mRNA and protein expression, respectively. A dual-luciferase assay was used to determine the direct targeting of the miR-29 cluster on the 3'-untranslated region (UTR) of the COL1A1 gene. RESULTS: The scleral expression of miR-29a, miR-29b, and miR-29c as well as MMP2 was significantly increased, and the scleral expression of COL1A1 was significantly decreased in the myopia group. Genipin treatment reversed these effects in myopic eyes. The dual-luciferase assay showed that the luciferase activities were significantly decreased in human embryonic kidney (HEK) cells transfected with miR-29a and miR-29b, but not miR-29c, compared with those transfected with control miRNAs. CONCLUSIONS: Genipin inhibits the scleral expression of the miR-29 cluster and MMP2 and promotes COL1A1 expression in a guinea pig model of myopia. Thus, genipin may promote COL1A1 expression by reducing the expression of the miR-29 cluster.
PURPOSE:High myopia can lead to blindness. Genipin is a collagen cross-linking agent that may be used to treat myopia. However, the mechanism of action of genipin for the treatment of myopia is unclear. This study investigated the effect of genipin on the scleral expression of the miR-29 cluster, matrix metalloproteinase 2 (MMP2), and collagen alpha1 chain of type I (COL1A1) in a guinea pig model of myopia. METHODS: The model of myopia was established by treating guinea pigs with a - 8D lens on both eyes for 21 days, and eyes with a refractive error of - 6D or greater were included. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) and western blot were used to examine the mRNA and protein expression, respectively. A dual-luciferase assay was used to determine the direct targeting of the miR-29 cluster on the 3'-untranslated region (UTR) of the COL1A1 gene. RESULTS: The scleral expression of miR-29a, miR-29b, and miR-29c as well as MMP2 was significantly increased, and the scleral expression of COL1A1 was significantly decreased in the myopia group. Genipin treatment reversed these effects in myopic eyes. The dual-luciferase assay showed that the luciferase activities were significantly decreased in humanembryonic kidney (HEK) cells transfected with miR-29a and miR-29b, but not miR-29c, compared with those transfected with control miRNAs. CONCLUSIONS: Genipin inhibits the scleral expression of the miR-29 cluster and MMP2 and promotes COL1A1 expression in a guinea pig model of myopia. Thus, genipin may promote COL1A1 expression by reducing the expression of the miR-29 cluster.
Authors: Ian C Campbell; Bailey G Hannon; A Thomas Read; Joseph M Sherwood; Stephen A Schwaner; C Ross Ethier Journal: J R Soc Interface Date: 2017-05 Impact factor: 4.118
Authors: Mustapha El Hamdaoui; Alexander M Levy; Aaron B Stuber; Christopher A Girkin; Timothy W Kraft; Brian C Samuels; Rafael Grytz Journal: Exp Eye Res Date: 2022-03-24 Impact factor: 3.770
Authors: Mustapha El Hamdaoui; Alexander M Levy; Mokshad Gaonkar; Timothy J Gawne; Christopher A Girkin; Brian C Samuels; Rafael Grytz Journal: Transl Vis Sci Technol Date: 2021-04-29 Impact factor: 3.283
Authors: B G Gerberich; B G Hannon; A Hejri; E J Winger; E Schrader Echeverri; L M Nichols; H G Gersch; N A MacLeod; S Gupta; A T Read; M D Ritch; S Sridhar; M G Toothman; G S Gershon; S A Schwaner; G Sánchez-Rodríguez; V Goyal; A M Toporek; A J Feola; H E Grossniklaus; M T Pardue; C R Ethier; M R Prausnitz Journal: Biomaterials Date: 2021-02-24 Impact factor: 12.479